Polymyxins: pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications (Q35623068)

9 August 2017

1 reference

title

Polymyxins: pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications (English)

1 reference

9 August 2017

1 reference

1 reference

1 reference

Elizabeth D Hermsen

1

1 reference

9 August 2017

Christopher J Sullivan

series ordinal

2

1 reference

9 August 2017

John C Rotschafer

series ordinal

3

1 reference

9 August 2017

publication date

1 September 2003

1 reference

Infectious Disease Clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

17

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

545-562

1 reference

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

A reassessment of the in-vitro activity of colistin sulphomethate sodium.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

The pharmacokinetics of colistin in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Colistin: an antimicrobial for the 21st century?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

An empirical approach to the treatment of multidrug-resistant ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Nebulizer choice for inhaled colistin treatment in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Colistin stimulates the activity of neutrophil elastase and Pseudomonas aeruginosa elastase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900058-8

7 January 2021

10.1016/S0891-5520(03)00058-8

Identifiers

DOI

1 reference

9 August 2017

1 reference